VACCINE COMPOSITION Russian patent published in 2008 - IPC A61K39/00 A61K38/08 

FIELD: medicine; pharmacology.

SUBSTANCE: invention refers to peptide including sequence R₁-XZXZ_NXZX-R₂, where: N means whole number within 3 to 7, preferentially 5, X means residue of positive common and/or uncommon amino acid, Z means residue of amino acid selected from number L, V, I, F and/or W, R₁ and R₂ are selected irrespectively from group consisting of -H, -NH₂, -COCH₃, -COH, peptides, consisting of 20 and less amino acid residues, chemically responsive groups of peptides, peptide linkers with or without peptide; X-R₂ also can represent amide, ester or thioester of chain-terminal amino acid, as adjuvant for immune response intensifying on at least one antigen.

EFFECT: intensifying of immune response on antigens.

16 cl, 3 ex, 3 dwg